Ixico
Phase 2IXI™ is IXICO’s proprietary, AI-enabled neuroimaging technology platform for precision medicine, purpose-built to drive clinical trial imaging and biomarker science insights in neurological disease research.
Founded
2004
Focus
AI / Machine Learning
About
IXI™ is IXICO’s proprietary, AI-enabled neuroimaging technology platform for precision medicine, purpose-built to drive clinical trial imaging and biomarker science insights in neurological disease research.
Funding History
2Total raised: $18.3M
IPO$12.8MN+1 SingerOct 3, 2014
Series A$5.5MAlbion VenturesApr 15, 2012
Company Info
TypePrivate
Founded2004
LocationLondon, United Kingdom
StagePhase 2
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile